On Friday, @StateDeptGHSD released its first wave of PEPFAR data, covering July-Sept 2025, after State took over USAID’s lifesaving health programs. Contrary to false media narratives, the data shows that President Trump’s foreign assistance review maintained and improved frontline lifesaving programs, while reducing NGO bloat and costs. During this transition period; - 20.6 million people w/ HIV received PEPFAR-supported antiretroviral treatment, exactly as many as during Biden’s last year - Early progress towards @SecRubio’s ambitious goal of ending mother-to-child transmission of HIV during @POTUS Trump’s second term, with preventive treatment initiated for 103k expectant/breastfeeding mothers, more than 2x as many as the same period a year earlier - Good initial progress moving programs, particularly in the treatment and testing space, to national health ministries as we champion self-reliance among health assistance countries This is all before the transformational investments in global health innovation and self-reliance made via the America First Global Health Strategy. Launched in Sept 2025, we have already signed 31 bilateral compacts worth more than $21 billion in U.S. commitments and country co-investment, and announced historic new innovation initiatives like our partnership with Gilead Sciences to get 3 million people in high-burden countries its new 99.9% effective twice yearly HIV prevention drug Lenacapavir. state.gov/releases/office-of…